QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module VIII: PASS Governance, Oversight and Quality Management

Test your understanding of the concepts covered by GVP Module VIII: PASS Governance, Oversight and Quality Management.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why is administrative study close-out not necessarily equivalent to pharmacovigilance closure?

The final report has no regulatory relevance Additional assessment or actions may remain, including RMP, signal, PSUR, regulatory, risk-minimisation or commitment follow-up All PASS must remain open indefinitely Only the vendor can determine whether PV closure has occurred

Question 2 of 10 Why should relevant PASS findings be made available to the PSUR process when applicable?

Because PSURs replace all PASS reporting Because periodic safety evaluation should reflect relevant current evidence, including findings managed by other departments Because every PASS result must be treated as a confirmed adverse reaction Because only final PASS findings may ever be communicated internally

Question 3 of 10 Which statement best describes appropriate QPPV oversight of a significant PASS?

The QPPV must personally manage every operational task The QPPV should have sufficient visibility of the study's purpose, status, major issues, findings and PV implications The QPPV only needs access to the final publication The QPPV's involvement is unnecessary when a CRO is used

Question 4 of 10 An MAH outsources database management and statistical programming for a PASS. Which governance principle applies?

The vendor becomes accountable for the MAH's regulatory responsibilities The MAH's responsibility is limited to reviewing the final invoice The MAH retains responsibility and must maintain appropriate oversight of the outsourced activities The QPPV must personally perform all outsourced activities

Question 5 of 10 What is the principal governance distinction between an imposed non-interventional PASS and a voluntary PASS?

Only imposed PASS require scientific integrity and data-quality controls Voluntary PASS are outside the pharmacovigilance quality system Imposed PASS have additional formal regulatory procedures and commitments that must be explicitly tracked Voluntary PASS cannot contribute to risk-management decisions

Question 6 of 10 Which control best supports traceability in PASS data management?

Keeping only the final table and deleting intermediate datasets Maintaining documented specifications, transformation rules, dataset versions, reconciliation and controlled database milestones Allowing each analyst to create undocumented derived variables Storing the analytical dataset only on a vendor's personal workstation

Question 7 of 10 Which evidence chain best reflects mature PASS governance?

Vendor invoice, publication draft and final presentation Study rationale, protocol, responsibilities, regulatory records, conduct, quality controls, data and analysis, final report and safety impact assessment Final report alone, provided it has been signed Meeting minutes without supporting data or decisions

Question 8 of 10 Which example best illustrates quality by design in a PASS?

Performing a single intensive QC review after the final report is drafted Prespecifying outcome definitions, validating data-source fitness and controlling transformations and analyses throughout the lifecycle Allowing analysts to revise definitions after seeing the main results Relying solely on the vendor's general certification

Question 9 of 10 Which root-cause analysis would most likely lead to effective CAPA after repeated late identification of critical data errors?

Classifying every occurrence as individual carelessness Repeating the same reminder to analysts without examining the process Assessing whether procedures, training, system design, resourcing, vendor performance or oversight caused the failure Closing the issue because the final report was eventually corrected

Question 10 of 10 Which management metric would provide more meaningful PASS oversight than schedule performance alone?

Number of meetings held, without considering their outcomes Number of invoices processed Unresolved critical deviations, major data-quality concerns and important emerging safety findings Number of slide presentations produced

GVP Module VIII: PASS Governance, Oversight and Quality Management

Cookie Settings